Holocene Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
AI
Holocene Advisors's HAE Position: Q2 2026 in Review
Holocene Advisors increased its Haemonetics (HAE) stake by 12,067% in Q2 2026, buying an estimated $35.1M and bringing the position to 550,195 shares worth $41.3M. The position accounts for 0.09% of the portfolio, ranked #214.
Holocene Advisors first reported a position in HAE in Q4 2017 and has held it in 18 quarters since. The position peaked at $101M in Q4 2025. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Holocene Advisors held 550,195 shares of Haemonetics worth $41.3M as of Q2 2026.
- Holocene Advisors bought 545,673 Haemonetics shares in Q2 2026, an estimated $35.1M.
- Haemonetics made up 0.09% of Holocene Advisors's portfolio in Q2 2026, its #214 holding.
- Holocene Advisors first reported a position in Haemonetics in Q4 2017 and has held it in 18 quarters since.
- Holocene Advisors's Haemonetics position peaked at $101M in Q4 2025.
- 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.